Prognostic Value of Mandard's Tumor Regression Grade (TRG) in Post Chemo-Radiotherapy Cervical Cancer

被引:2
作者
Scaglione, Giulia [1 ]
Arciuolo, Damiano [1 ]
Travaglino, Antonio [1 ,2 ]
Santoro, Angela [1 ]
Angelico, Giuseppe [3 ]
Spadola, Saveria [3 ]
Inzani, Frediano [4 ]
D'Alessandris, Nicoletta [1 ]
Raffone, Antonio [5 ]
Fulgione, Caterina [6 ]
Urtueta, Belen Padial [1 ]
Sfregola, Stefania [1 ]
Valente, Michele [1 ]
Addante, Francesca [1 ]
d'Amati, Antonio [7 ]
Cianfrini, Federica [1 ]
Piermattei, Alessia [1 ]
Anchora, Luigi Pedone [8 ]
Scambia, Giovanni [8 ]
Ferrandina, Gabriella [8 ]
Zannoni, Gian Franco [1 ]
机构
[1] Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Woman & Childs Hlth & Publ Hlth Sci, Gynecopathol & Breast Pathol Unit, I-00168 Rome, Italy
[2] Univ Insubria, Dept Med & Technol Innovat, Pathol Unit, I-21100 Varese, Italy
[3] Cannizzaro Hosp, Pathol Unit, I-95126 Catania, Italy
[4] Univ Pavia, Dept Mol Med, Anat Pathol Unit, I-27100 Pavia, Italy
[5] Univ Bologna, Dept Med & Surg Sci DIMEC, I-40126 Bologna, Italy
[6] Federico II Univ Naples, Dept Neurosci Reprod Sci & Dent, Gynecol & Obstet Unit, I-80131 Naples, Italy
[7] Univ Bari Aldo Moro, Dept Precis & Regenerat Med & Ionian Area DiMePRe, I-70100 Bari, Italy
[8] Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Woman & Childs Hlth & Publ Hlth Sci, Gynecol Oncol Unit, I-00168 Rome, Italy
关键词
locally advanced cervical cancer; Mandard scoring system; prognostic stratification; SQUAMOUS-CELL CARCINOMA; LYMPHOVASCULAR SPACE INVASION; NEOADJUVANT CHEMOTHERAPY; PATHOLOGICAL-RESPONSE; UTERINE CERVIX; ADENOCARCINOMA; ESOPHAGEAL; SURGERY; RADIOCHEMOTHERAPY; CHEMORADIATION;
D O I
10.3390/diagnostics13203228
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In locally advanced cervical cancer (LACC), definitive chemo-radiotherapy is the standard treatment, but chemo-radiotherapy followed by surgery could be an alternative choice in selected patients. We enrolled 244 patients affected by LACC and treated with CT-RT followed by surgery in order to assess the prognostic role of the histological response using the Mandard scoring system. Results: A complete pathological response (TRG 0) was observed in 118 patients (48.4%), rare residual cancer cells (TRG2) were found in 49 cases (20.1%), increased number of cancer cells but fibrosis still predominating (TRG3) in 35 cases (14.3%), and 42 (17.2%) were classified as non-responders (TRG4-5). TRG was significantly associated with both OS (p < 0.001) and PFS (p < 0.001). The survival curves highlighted two main prognostic groups: TRG1-TRG2 and TRG3-TRG4-5. Main responders (TRG1-2) showed a 92% 5-year overall survival (5y-OS) and a 75% 5-year disease free survival (5y-DFS). Minor or no responders showed a 48% 5y-OS and a 39% 5y-DFS. The two-tiered TRG was independently associated with both DFS and OS in Cox regression analysis. Conclusion. We showed that Mandard TRG is an independent prognostic factor in post-CT/RT LACC, with potential benefits in defining post-treatment adjuvant therapy.
引用
收藏
页数:13
相关论文
共 62 条
[1]   Preoperative chemoradiation followed by hysterectomy for cervical cancer: patterns of care and survival in a large, hospital database [J].
Albert, Ashley ;
Allbright, Robert ;
Lee, Anna ;
Vijayakumar, Srinivasan .
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (03)
[2]  
[Anonymous], 2010, SAO PAULO MED J, V128, P177
[3]   Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma [J].
Aoki, Y ;
Sato, T ;
Watanabe, M ;
Sasaki, M ;
Tsuneki, I ;
Tanaka, K .
GYNECOLOGIC ONCOLOGY, 2001, 81 (03) :496-499
[4]   Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study [J].
Atahan, I. L. ;
Onal, C. ;
Ozyar, E. ;
Yiliz, F. ;
Selek, U. ;
Kose, F. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (04) :833-842
[5]   Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy [J].
Becker, K ;
Mueller, JD ;
Schulmacher, C ;
Ott, K ;
Fink, U ;
Busch, R ;
Böttcher, K ;
Siewert, JR ;
Höfler, H .
CANCER, 2003, 98 (07) :1521-1530
[6]   Revised FIGO staging for carcinoma of the cervix uteri [J].
Bhatla, Neerja ;
Berek, Jonathan S. ;
Cuello Fredes, Mauricio ;
Denny, Lynette A. ;
Grenman, Seija ;
Karunaratne, Kanishka ;
Kehoe, Sean T. ;
Konishi, Ikuo ;
Olawaiye, Alexander B. ;
Prat, Jaime ;
Sankaranarayanan, Rengaswamy .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 145 (01) :129-135
[7]   Cancer of the cervix uteri [J].
Bhatla, Neerja ;
Aoki, Daisuke ;
Sharma, Daya Nand ;
Sankaranarayanan, Rengaswamy .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2018, 143 :22-36
[8]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
[9]   Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer Validity of Pathological Response as Surrogate Endpoint of Survival [J].
Buda, Alessandro ;
Lissoni, Andrea Alberto ;
Floriani, Irene ;
Biagioli, Elena ;
Gerardi, Chiara ;
Bonazzi, Cristina ;
Chiari, Stefania ;
Locatelli, Luca ;
Dell'Anna, Tiziana ;
Signorelli, Mauro ;
Mangioni, Costantino ;
Milani, Rodolfo .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (08) :1468-1475
[10]  
Candelaria Myrna, 2006, Int Semin Surg Oncol, V3, P3, DOI 10.1186/1477-7800-3-3